2024 MS Research: Reflecting on Key Insights

Hello, MS warriors and curious minds! Let’s dive into some exciting updates from the world of MS (Multiple Sclerosis) research as of November 2024. These findings, reviewed by MSAA Chief Medical Officer Dr. Barry A. Hendin, offer hope and progress for everyone affected by MS.

Starting Strong: The “start strong” approach with high-efficacy therapies for MS is gaining momentum. Two Swedish studies show that starting treatment early with these medications improves long-term outcomes and helps people stay in the workforce longer.

Infectious Link: Researchers have identified a significant connection between infectious mononucleosis, caused by Epstein-Barr Virus, and MS risk. These studies highlight the importance of prevention and early monitoring.

 A minimalist illustration of a sunrise over a calm sea, symbolizing hope and progress in multiple sclerosis research.
A tranquil sunrise over a calm sea, representing optimism in MS research advancements.

Menopause Relief: New research brings reassurance to women with MS. Menopause is not a trigger for increased disability progression.

Lesion Control: Tolebrutinib, an oral medication, has shown a 31% delay in disability progression for those with non-relapsing secondary-progressive MS (SPMS). Encouraging results have also been seen in trials for relapsing MS.

Mediterranean Boost and more!

Mediterranean Boost: Following a Mediterranean Diet is linked to better mental health and quality of life for people with MS. Enjoying fruits, vegetables, and olive oil could make a big difference!

Vitamin D Spotlight: High-dose Vitamin D supplementation has been found to reduce disease activity in early MS. If you’re considering supplements, consult your doctor for personalized advice.

Diagnostic Enhancements: Updates to the McDonald Criteria aim to makey diagnosing MS faster and more accurate. New tools like kappa free light chains and revised criteria are part of these improvements.

You can find more in MS Research
Also, you can visit my ETSY store to find some items you can like and buy 🙂 ETSY LINK

Steroid Power: A study suggests that treating MS relapses with corticosteroids may help slow long-term disability progression. This adds an unexpected benefit to a common treatment.

Sleep and Quality of Life: Danish research confirms what we’ve all suspected: better sleep leads to a better quality of life for those with MS. Addressing sleep issues is crucial for managing the disease.

Pregnancy and MS: Good news for expecting mothers with MS! Most MS medications do not increase the risks of miscarriage or birth defects. However, careful monitoring is still essential as babies may be smaller at birth.

Brain Boost from Gait Training: A small German study suggests that physical therapy focused on walking can improve brain white matter integrity. Movement can truly matter!

Frexalimab Progress: Frexalimab, an investigational therapy, has shown sustained efficacy and safety over 18 months. It continues to reduce lesions and MS activity.

You can access the full article here: What’s New in MS Research – November 2024.

This article is a snapshot of the latest and greatest in MS research, gathered in one place. From cutting-edge treatments to lifestyle tips, it’s all about making life with MS brighter. Keep shining, MS warriors! 🌟🧡

Also you can read;

Leave a Reply